Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marshall Posner

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
The Oncologist|September 17, 2013
Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neckLale Kostakoglu, Reza Fardanesh, Marshall Posner, et al.
Diagnostic Cytopathology|September 5, 2020
Liquid phase human papillomavirus genotype analysis of aspirated metastatic head and neck squamous cell carcinoma: Fine needle aspiration supernatant is a rich source of tumor DNA that can increase the diagnostic yieldYansheng Hao, Meenakshi Mehrotra, Hansen Lam, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancerMark S Chambers, Marshall Posner, Christopher Uwe Jones, et al.
Head & Neck|April 19, 2019
Trimodality therapy for oropharyngeal cancer in the TORS era: Is there a cohort that may benefit?Matthew Gallitto, Kunal Sindhu, Isaac Wasserman, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 4, 2012
Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should knowEric M Genden, Ian M Sambur, John R de Almeida, et al.
Cancer|July 28, 2009
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancerRobert Haddad, Stephen Sonis, Marshall Posner, et al.
Oral Oncology|May 11, 2015
HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking statusKaren S Anderson, Kristina R Dahlstrom, Julia N Cheng, et al.
Head & Neck|April 19, 2013
Preferences and utilities for health states after treatment for oropharyngeal cancer: transoral robotic surgery versus definitive (chemo)radiotherapyJohn R de Almeida, Nathaniel L Villanueva, Alan J Moskowitz, et al.
The Oncologist|August 13, 2024
Association of human papillomavirus genotype and phylogenic clade with oropharyngeal cancer outcomesMichael T Wotman, Tara Ivic-Pavlicic, William H Westra, et al.
Head & Neck|December 10, 2014
Cost-effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost-utility analysisJohn R de Almeida, Alan J Moskowitz, Brett A Miles, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
The Oncologist|September 17, 2013
Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neckLale Kostakoglu, Reza Fardanesh, Marshall Posner, et al.
Diagnostic Cytopathology|September 5, 2020
Liquid phase human papillomavirus genotype analysis of aspirated metastatic head and neck squamous cell carcinoma: Fine needle aspiration supernatant is a rich source of tumor DNA that can increase the diagnostic yieldYansheng Hao, Meenakshi Mehrotra, Hansen Lam, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancerMark S Chambers, Marshall Posner, Christopher Uwe Jones, et al.
Head & Neck|April 19, 2019
Trimodality therapy for oropharyngeal cancer in the TORS era: Is there a cohort that may benefit?Matthew Gallitto, Kunal Sindhu, Isaac Wasserman, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 4, 2012
Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should knowEric M Genden, Ian M Sambur, John R de Almeida, et al.
Cancer|July 28, 2009
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancerRobert Haddad, Stephen Sonis, Marshall Posner, et al.
Oral Oncology|May 11, 2015
HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking statusKaren S Anderson, Kristina R Dahlstrom, Julia N Cheng, et al.
Head & Neck|April 19, 2013
Preferences and utilities for health states after treatment for oropharyngeal cancer: transoral robotic surgery versus definitive (chemo)radiotherapyJohn R de Almeida, Nathaniel L Villanueva, Alan J Moskowitz, et al.
The Oncologist|August 13, 2024
Association of human papillomavirus genotype and phylogenic clade with oropharyngeal cancer outcomesMichael T Wotman, Tara Ivic-Pavlicic, William H Westra, et al.
Head & Neck|December 10, 2014
Cost-effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost-utility analysisJohn R de Almeida, Alan J Moskowitz, Brett A Miles, et al.
Pageof 10